Welcome to LookChem.com Sign In|Join Free
  • or
C19H16N4O3 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1085709-10-9

Post Buying Request

1085709-10-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1085709-10-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1085709-10-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,5,7,0 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1085709-10:
(9*1)+(8*0)+(7*8)+(6*5)+(5*7)+(4*0)+(3*9)+(2*1)+(1*0)=159
159 % 10 = 9
So 1085709-10-9 is a valid CAS Registry Number.

1085709-10-9Upstream product

1085709-10-9Relevant academic research and scientific papers

Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives

Lopes-Ortiz, Mariana Aparecida,Panice, Manuela Ribeiro,Borges de Melo, Eduardo,Ataide Martins, Jo?o Paulo,Baldin, Vanessa Pietrowski,Agostinho Pires, Cláudia Terêncio,Caleffi-Ferracioli, Katiany Rizzieri,Dias Siqueira, Vera Lúcia,Bertin de Lima Scodro, Regiane,Sarragiotto, Maria Helena,Cardoso, Rosilene Fressatti

, (2020)

A series of methyl β-carboline carboxylates (2a-g) and of imide-β-carboline derivatives containing the phthalimide (4a-g), maleimide (5b, g) and succinimide (6b, e, g) moiety were synthesized, and evaluated for their activity against Mycobacterium tuberculosis H37Rv. The most active β-carboline derivatives against the reference strain were assayed for their cytotoxicity and the activity against resistant M. tuberculosis clinical isolates. Farther, structure-activity relationship (SAR) studies were carried out using the three and four-dimensional approaches for starting to understand the way of β-carboline activity in M. tuberculosis. All 19 β-carboline derivatives were assayed, firstly, by determining the minimum inhibitory concentration (MIC) using resazurin microtiter assay plate (REMA) in M. tuberculosis H37Rv. Then, five derivatives (2c, 4a, 4e, 4g, 6g), which showed MIC ≤ 125 μg/mL, were assayed in nine resistant M. tuberculosis clinical isolates (five MDR, three isoniazid monoresistant and one isoniazid plus streptomycin resistant). The MIC values against the resistant clinical isolates ranged from 31.25 to >250 μg/mL. All five derivatives were non-cytotoxic to the VERO cell line, determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, at the tested concentration (selectivity index ranged from 1.74 to 14.4). Our study demonstrated that (2c) and (6g) derivatives had better anti-M. tuberculosis activity, especially against resistant clinical isolates, what makes them scaffold candidates for further investigations about their anti-tuberculosis activity. The SAR study conducted with the 19 β-carboline derivatives showed the importance of steric effects for the synthesized β-carbolines against M tuberculosis, and these models can be used for future proposition of new derivatives, increasing the chances of obtaining potentially anti-tuberculosis compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1085709-10-9